SCYNEXIS
SCYX
#10667
Rank
โ‚ฌ21.59 M
Marketcap
2,17ย โ‚ฌ
Share price
-8.64%
Change (1 day)
324.16%
Change (1 year)

Earnings for SCYNEXIS (SCYX)

Earnings in 2026 (TTM): -โ‚ฌ8.81 Million

According to SCYNEXIS's latest financial reports the company's current earnings are โ‚ฌ19.21 Million. In 2025 the company made an earning of -โ‚ฌ7.7 Million, an increase over its 2024 earnings that were of -โ‚ฌ18.51 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for SCYNEXIS from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ8.81 Million14.52%
2025 -โ‚ฌ7.7 Million-58.45%
2024 -โ‚ฌ18.51 Million-128.88%
2023 โ‚ฌ64.09 M-212.84%
2022 -โ‚ฌ56.81 Million87.15%
2021 -โ‚ฌ30.36 Million-41.74%
2020 -โ‚ฌ52.1 Million8.41%
2019 -โ‚ฌ48.06 Million205.58%
2018 -โ‚ฌ15.73 Million-25.66%
2017 -โ‚ฌ21.16 Million-31.73%
2016 -โ‚ฌ30.99 Million19.9%
2015 -โ‚ฌ25.85 Million111.45%
2014 -โ‚ฌ12.23 Million-27.82%
2013 -โ‚ฌ16.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Galmed Pharmaceuticals
GLMD
-โ‚ฌ10.35 Million 10.83%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
โ‚ฌ0.27 B-2,996.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-โ‚ฌ82.96 Million 789.11%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
-โ‚ฌ38.2 Million 309.39%๐Ÿ‡บ๐Ÿ‡ธ USA